Kenneth Cunningham is Director of Verona Pharma plc. Currently has a direct ownership of 66,584 shares of VRNA, which is worth approximately $2.52 Million. The most recent transaction as insider was on May 04, 2021, when has been sold 13,112 shares (Ordinary Shares) at a price of $0.84 per share, resulting in proceeds of $11,014. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.6K
0% 3M change
0% 12M change
Total Value Held $2.52 Million

Kenneth Cunningham Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 04 2021
SELL
Open market or private sale
$11,014 $0.84 p/Share
13,112 Reduced 16.45%
66,584 Ordinary Shares
Feb 01 2021
SELL
Open market or private sale
$12,973 $0.99 p/Share
13,104 Reduced 14.12%
79,696 Ordinary Shares
KC

Kenneth Cunningham

Director
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA